iSpecimen (ISPC) Gross Profit (2020 - 2026)

iSpecimen's Gross Profit history runs 7 years deep, the most recent figure standing at -$1.4 million for Q1 2026.

• In Q1 2026, Gross Profit fell 295.15% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$2.3 million (down 160.47% YoY), while the FY2025 annual figure was -$366503.0, down 108.77% from the prior year.
• Gross Profit was -$1.4 million for Q1 2026 at iSpecimen, down from -$1.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $2.0 million in Q4 2022 to a low of -$1.4 million in Q1 2026.
• Historically, Gross Profit has averaged $932813.4 across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Gross Profit soared 175.06% in 2024, then plunged 642.74% in 2025.
• A 5-year view of Gross Profit shows it stood at $2.0 million in 2022, then dropped by 1.69% to $2.0 million in 2023, then sank by 90.1% to $199241.0 in 2024, then slumped by 642.74% to -$1.1 million in 2025, then retreated by 28.2% to -$1.4 million in 2026.
• The last three Gross Profit figures came in at -$1.4 million (Q1 2026), -$1.1 million (Q4 2025), and -$98001.0 (Q3 2025), per Business Quant data.